APP下载

布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘急性发作的疗效观察

2015-08-06刘俊锋庚俐莉

中国医药科学 2015年11期

刘俊锋 庚俐莉

[摘要] 目的 探讨布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘急性发作的疗效。 方法 选取支气管哮喘急性发作患者80例采用随机数字表分为观察组(布地奈德联合沙丁胺醇雾化吸入治疗)和对照组(沙丁胺醇雾化吸入治疗),每组各40例,观察并比较两组患者治疗前后FEV1和FVC的变化及两组患者咳嗽、胸闷、气短消失时间及哮鸣音消失时间,并进行疗效评价。 结果 观察组患者的FEV1和FVC均较治疗前及对照组显著改善 (P<0.05)。观察组患咳嗽、胸闷、气短消失时间及哮鸣音消失时间均显著快于对照组 (P<0.05)。观察组的总有效率达95.00%,显著高于对照组75.00%(P<0.05)。 结论 布地奈德联合沙丁胺醇雾化吸入治疗支气管哮喘急性发作能明显改善患者的临床症状及肺功能,从而提高疗效。

[关键词] 支气管哮喘急性发作;布地奈德;沙丁胺醇;雾化吸入

[中图分类号] R562.25 [文献标识码] B [文章编号] 2095-0616(2015)11-72-03

[Abstract] Objective To investigate the curative effect of budesonide combined with salbutamol atomization inhalation in treatment of acute attack of bronchial asthma. Methods Selected 80 patients with acute attack of bronchial asthma were randomly divided into observation group(budesonide combined with salbutamol atomization inhalation therapy) and control group (salbutamol treatment), 40 patients in each group,changes of FEV1 and FVC and cough, chest tightness, shortness of breath group disappearance time and wheeze disappeared time were compared, and valuated the curative effect. Results After treatment,the FEV1 and FVC improved significantly than before treatment and control group(P<0.05).The cough, chest tightness, shortness of breath, lost time and wheeze disappeared time of observation group was significantly faster than the control group(P<0.05).The total effective rate of the observation group was 95.00%, significantly higher than 75.00% the control group(P<0.05). Conclusion Inhaled budesonide combined with salbutamol in treatment acute attack of bronchial asthma curative effect is good and safe.

[Key words] Acute attack of bronchial asthma; Budesonide; Salbutamol; Atomization inhalation

支气管哮喘是呼吸系统的常见病、多发病,哮喘急性发作是指突然发生喘息、气促、咳嗽、胸闷等症状,或原有症状急剧加重,常伴呼吸困难[1]。雾化吸入法以其见效快、直接达到局部、药物用量小、不良反应轻,作为平喘、消炎、化痰、改善通气的重要手段。雾化吸入布地奈德混悬液及沙丁胺醇溶液直接作用于气道局部,成为治疗支气管哮喘急性发作的首选方法[2],现报道如下。

1 资料与方法

1.1 一般资料

选取2012年1月~2014年1月收治的支气管哮喘急性发作患者80例,其中男46例,女34例,年龄18~70岁,平均(44.2±7.3)岁。全部患者根据治疗方法不同分为观察组和对照组,每组各40例,两组入选病例的性别、年龄、病程、临床表现、哮喘病情程度等临床资料比较差异无统计学意义(P>0.05)。见表1。

1.2 治疗方法

两组均予吸氧、抗炎、镇咳、祛痰等常规治疗。对照组同时联合沙丁胺醇(深圳大佛药业有限公司,H20000348)1mL,0.9%氯化钠溶液2.5mL雾化吸入,每天3次,每次15min。……

登录APP查看全文